CN109813918A - 一种总胆红素测定试剂盒 - Google Patents
一种总胆红素测定试剂盒 Download PDFInfo
- Publication number
- CN109813918A CN109813918A CN201910027801.XA CN201910027801A CN109813918A CN 109813918 A CN109813918 A CN 109813918A CN 201910027801 A CN201910027801 A CN 201910027801A CN 109813918 A CN109813918 A CN 109813918A
- Authority
- CN
- China
- Prior art keywords
- reagent
- bilirubin
- total bilirubin
- interference
- adjusting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 48
- 238000008050 Total Bilirubin Reagent Methods 0.000 title claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000003002 pH adjusting agent Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 3
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 3
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 3
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical group CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 17
- 238000001514 detection method Methods 0.000 abstract description 11
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 abstract description 10
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 abstract description 8
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 5
- 235000010288 sodium nitrite Nutrition 0.000 abstract description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 abstract description 2
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 abstract description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 abstract description 2
- 235000017858 Laurus nobilis Nutrition 0.000 abstract description 2
- 229910002651 NO3 Inorganic materials 0.000 abstract description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 abstract description 2
- 244000125380 Terminalia tomentosa Species 0.000 abstract description 2
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 abstract description 2
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 abstract description 2
- 150000002500 ions Chemical class 0.000 abstract description 2
- 229940094506 lauryl betaine Drugs 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 229910021645 metal ion Inorganic materials 0.000 abstract description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 abstract description 2
- -1 polyoxyethylene Polymers 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 230000002335 preservative effect Effects 0.000 abstract description 2
- 230000036632 reaction speed Effects 0.000 abstract description 2
- 239000011734 sodium Substances 0.000 abstract description 2
- 239000011780 sodium chloride Substances 0.000 abstract description 2
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- WQEVDHBJGNOKKO-UHFFFAOYSA-K vanadic acid Chemical compound O[V](O)(O)=O WQEVDHBJGNOKKO-UHFFFAOYSA-K 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 2
- 108010015428 Bilirubin oxidase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- AISMNBXOJRHCIA-UHFFFAOYSA-N trimethylazanium;bromide Chemical compound Br.CN(C)C AISMNBXOJRHCIA-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229910001456 vanadium ion Inorganic materials 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
项目名称 | 校准浓度(μmol/L) | 质控浓度(μmol/L) | 临床血清检测结果(μmol/L) |
TBIL | 87.1 | 29.3 | 15.3 |
TBIL | 87.1 | 29.2 | 15.7 |
TBIL | 87.1 | 29.5 | 14.9 |
项目名称 | 校准浓度(μmol/L) | 质控浓度(μmol/L) | 临床血清检测结果(μmol/L) |
TBIL | 87.1 | 28.4 | 23.3 |
TBIL | 87.1 | 30.2 | 21.4 |
TBIL | 87.1 | 31.7 | 28.7 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027801.XA CN109813918B (zh) | 2019-01-11 | 2019-01-11 | 一种总胆红素测定试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027801.XA CN109813918B (zh) | 2019-01-11 | 2019-01-11 | 一种总胆红素测定试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109813918A true CN109813918A (zh) | 2019-05-28 |
CN109813918B CN109813918B (zh) | 2021-04-09 |
Family
ID=66603465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910027801.XA Active CN109813918B (zh) | 2019-01-11 | 2019-01-11 | 一种总胆红素测定试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109813918B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113624701A (zh) * | 2021-07-30 | 2021-11-09 | 浙江夸克生物科技有限公司 | 一种结合胆红素测定试剂盒 |
CN113916816A (zh) * | 2021-10-16 | 2022-01-11 | 湖南永和阳光生物科技股份有限公司 | 一种用于直接胆红素测定的试剂盒 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0087150A1 (en) * | 1982-02-22 | 1983-08-31 | Seragen Diagnostics, Inc. | Process, reagent and kit for the assay of total bilirubin |
CN1967252A (zh) * | 2006-10-30 | 2007-05-23 | 宁波美康生物科技有限公司 | 直接胆红素测定试剂盒 |
CN101109754A (zh) * | 2007-07-23 | 2008-01-23 | 宁波美康生物科技有限公司 | 胆红素测定冻干校正液及其制备方法 |
CN101231243A (zh) * | 2007-01-24 | 2008-07-30 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞检测试剂及检测方法 |
CN104406971A (zh) * | 2014-11-28 | 2015-03-11 | 山东博科生物产业有限公司 | 一种直接胆红素检测试剂 |
CN105092573A (zh) * | 2015-09-02 | 2015-11-25 | 郁东 | 一种新型的直接胆红素检测试剂盒 |
CN106404686A (zh) * | 2016-08-27 | 2017-02-15 | 山东博科生物产业有限公司 | 一种抗肝素的血清总胆红素(钒酸盐氧化法)检测试剂盒 |
CN106814037A (zh) * | 2015-11-30 | 2017-06-09 | 山东博科生物产业有限公司 | 一种亚硝酸钠法总胆红素(氧化法)检测试剂盒 |
CN107091934A (zh) * | 2016-02-18 | 2017-08-25 | 四川新健康成生物股份有限公司 | 一种直接胆红素测定试剂盒及配置方法以及其运用 |
JP2017173011A (ja) * | 2016-03-22 | 2017-09-28 | ニプロ株式会社 | 抱合型ビリルビン測定用試薬 |
WO2018056431A1 (ja) * | 2016-09-26 | 2018-03-29 | 池田食研株式会社 | L-キヌレニンの測定方法及び測定キット |
WO2018109004A1 (en) * | 2016-12-14 | 2018-06-21 | Roche Diagnostics Gmbh | Determination of interferents in a sample |
WO2018141017A1 (en) * | 2017-02-01 | 2018-08-09 | Murdoch Childrens Research Institute | Absorbent article with indicator |
CN109097436A (zh) * | 2018-08-10 | 2018-12-28 | 山东博科生物产业有限公司 | 一种准确高效的单一试剂的低密度脂蛋白胆固醇检测试剂 |
-
2019
- 2019-01-11 CN CN201910027801.XA patent/CN109813918B/zh active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0087150A1 (en) * | 1982-02-22 | 1983-08-31 | Seragen Diagnostics, Inc. | Process, reagent and kit for the assay of total bilirubin |
CN1967252A (zh) * | 2006-10-30 | 2007-05-23 | 宁波美康生物科技有限公司 | 直接胆红素测定试剂盒 |
CN101231243A (zh) * | 2007-01-24 | 2008-07-30 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞检测试剂及检测方法 |
CN101109754A (zh) * | 2007-07-23 | 2008-01-23 | 宁波美康生物科技有限公司 | 胆红素测定冻干校正液及其制备方法 |
CN104406971A (zh) * | 2014-11-28 | 2015-03-11 | 山东博科生物产业有限公司 | 一种直接胆红素检测试剂 |
CN105092573A (zh) * | 2015-09-02 | 2015-11-25 | 郁东 | 一种新型的直接胆红素检测试剂盒 |
CN106814037A (zh) * | 2015-11-30 | 2017-06-09 | 山东博科生物产业有限公司 | 一种亚硝酸钠法总胆红素(氧化法)检测试剂盒 |
CN107091934A (zh) * | 2016-02-18 | 2017-08-25 | 四川新健康成生物股份有限公司 | 一种直接胆红素测定试剂盒及配置方法以及其运用 |
JP2017173011A (ja) * | 2016-03-22 | 2017-09-28 | ニプロ株式会社 | 抱合型ビリルビン測定用試薬 |
CN106404686A (zh) * | 2016-08-27 | 2017-02-15 | 山东博科生物产业有限公司 | 一种抗肝素的血清总胆红素(钒酸盐氧化法)检测试剂盒 |
WO2018056431A1 (ja) * | 2016-09-26 | 2018-03-29 | 池田食研株式会社 | L-キヌレニンの測定方法及び測定キット |
WO2018109004A1 (en) * | 2016-12-14 | 2018-06-21 | Roche Diagnostics Gmbh | Determination of interferents in a sample |
WO2018141017A1 (en) * | 2017-02-01 | 2018-08-09 | Murdoch Childrens Research Institute | Absorbent article with indicator |
CN109097436A (zh) * | 2018-08-10 | 2018-12-28 | 山东博科生物产业有限公司 | 一种准确高效的单一试剂的低密度脂蛋白胆固醇检测试剂 |
Non-Patent Citations (2)
Title |
---|
CHAO LU 等: "Determination of total bilirubin in human serum by chemiluminescence from the reaction of bilirubin and peroxynitrite", 《TALANTA》 * |
彭梅 等: "5种总胆红素测定试剂盒的比较分析", 《检验医学与临床》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113624701A (zh) * | 2021-07-30 | 2021-11-09 | 浙江夸克生物科技有限公司 | 一种结合胆红素测定试剂盒 |
CN113916816A (zh) * | 2021-10-16 | 2022-01-11 | 湖南永和阳光生物科技股份有限公司 | 一种用于直接胆红素测定的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN109813918B (zh) | 2021-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hadwan | New method for assessment of serum catalase activity | |
CN104198473B (zh) | 一种稳定的尿酸检测试剂盒 | |
Krishnegowda et al. | Spectrophotometric assay of creatinine in human serum sample | |
CN106383116A (zh) | 一种检测高密度脂蛋白胆固醇的试剂盒 | |
US8883439B2 (en) | Blood component measurement method utilizing hemolyzed whole blood, and kit for the method | |
JP5906604B2 (ja) | 全血検体の成分測定方法 | |
Dubourg et al. | Adaptation of an enzymatic polyfructosan assay to clinical practice | |
CN109613226B (zh) | 一种肌酐测定试剂盒及其应用 | |
CN109813918A (zh) | 一种总胆红素测定试剂盒 | |
CN112029817B (zh) | 一种肌酐检测试剂盒及其使用方法 | |
CN107505273A (zh) | 血清总胆汁酸含量测定试剂盒及其使用方法 | |
CN106191211B (zh) | 一种用于高密度脂蛋白胆固醇检测试剂的稳定剂 | |
CN107505470A (zh) | 稳定的肌酐检测试剂盒及其使用方法 | |
CN112710853B (zh) | 一种抗干扰、稳定的血清直接胆红素(酶法)测定试剂盒及其制备方法和应用 | |
CN108613976A (zh) | 直接胆红素检测试剂盒 | |
CN106404686A (zh) | 一种抗肝素的血清总胆红素(钒酸盐氧化法)检测试剂盒 | |
Akram et al. | Development and validation of an economical uric acid-Fe3+/Fe2+-ferrozine-based colorimetric assay to estimate uric acid level of pure and biological samples | |
JP7484998B2 (ja) | 測定感度を改善した生体成分測定キット及び生体成分測定方法 | |
Ng et al. | Maltose interference-free test strips for blood glucose testing at point-of-care: a laboratory performance evaluation | |
CN102323225B (zh) | 一种检测低密度脂蛋白胆固醇的方法和试剂盒 | |
CN104673878B (zh) | 一种单体系测定糖化白蛋白与白蛋白浓度比值的试剂盒 | |
CN109541238A (zh) | 直接胆红素测定方法及试剂盒 | |
CN112710854B (zh) | 一种抗干扰、稳定的血清总胆红素(酶法)测定试剂盒及其制备方法和应用 | |
CN113916816A (zh) | 一种用于直接胆红素测定的试剂盒 | |
JPWO2006030866A1 (ja) | 尿酸の定量方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210107 Address after: No.219, Yuquan Road, Luquan District, Shijiazhuang City, Hebei Province Applicant after: Hebei Institute of drug and medical device inspection Applicant after: HEBEI AIOULU BIOTECHNOLOGY Co.,Ltd. Address before: 050000 No.228 Zhonghua North Street, Shijiazhuang, Hebei Province Applicant before: HEBEI INSTITUTE OF MEDICAL DEVICE AND PHARMACEUTICAL PACKAGING MATERIALS INSPECTION (HEBEI PROVINCE MEDICAL DEVICE TECHNOLOGY EVALUATION CENTER) Applicant before: HEBEI AIOULU BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.219, Yuquan Road, Luquan District, Shijiazhuang City, Hebei Province Patentee after: Hebei Institute for drug and medical device inspection (Hebei cosmetic inspection and Research Center) Patentee after: HEBEI AIOULU BIOTECHNOLOGY Co.,Ltd. Address before: No.219, Yuquan Road, Luquan District, Shijiazhuang City, Hebei Province Patentee before: Hebei Institute of drug and medical device inspection Patentee before: HEBEI AIOULU BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190528 Assignee: LANGFANG HENGYI BIOTECHNOLOGY Co.,Ltd. Assignor: Hebei Institute for drug and medical device inspection (Hebei cosmetic inspection and Research Center) Contract record no.: X2022130000022 Denomination of invention: A total bilirubin test kit Granted publication date: 20210409 License type: Common License Record date: 20220926 |